Lawreen H. Connors

7.0k total citations
111 papers, 5.1k citations indexed

About

Lawreen H. Connors is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Lawreen H. Connors has authored 111 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 28 papers in Oncology and 28 papers in Cell Biology. Recurrent topics in Lawreen H. Connors's work include Amyloidosis: Diagnosis, Treatment, Outcomes (102 papers), Parathyroid Disorders and Treatments (22 papers) and Protein Kinase Regulation and GTPase Signaling (19 papers). Lawreen H. Connors is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (102 papers), Parathyroid Disorders and Treatments (22 papers) and Protein Kinase Regulation and GTPase Signaling (19 papers). Lawreen H. Connors collaborates with scholars based in United States, Italy and Canada. Lawreen H. Connors's co-authors include Martha Skinner, Catherine E. Costello, David C. Seldin, Tatiana Prokaeva, Rodney H. Falk, Ronglih Liao, Amareth Lim, Roger Théberge, John L. Berk and Alan S. Cohen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lawreen H. Connors

111 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawreen H. Connors United States	39	4.6k	1.2k	1.2k	980	640	111	5.1k
Nina Jones Canada	30	2.1k 0.5×	940 0.8×	440 0.4×	203 0.2×	379 0.6×	59	3.3k
Kyle D. Mansfield United States	23	3.7k 0.8×	160 0.1×	628 0.5×	674 0.7×	259 0.4×	32	5.6k
Debra K. Newman United States	37	2.1k 0.5×	215 0.2×	355 0.3×	323 0.3×	288 0.5×	109	4.5k
Joyce T. O’Connell United States	11	3.0k 0.6×	419 0.3×	701 0.6×	194 0.2×	236 0.4×	12	4.2k
Ingo Flamme Germany	32	4.1k 0.9×	118 0.1×	677 0.6×	397 0.4×	819 1.3×	49	6.1k
Gopal P. Sapkota United Kingdom	33	3.9k 0.8×	111 0.1×	1.1k 0.9×	291 0.3×	790 1.2×	67	4.8k
Naoyuki Miura Japan	42	3.8k 0.8×	135 0.1×	2.9k 2.4×	711 0.7×	760 1.2×	96	6.7k
Andrei V. Bakin United States	36	4.8k 1.0×	136 0.1×	1.8k 1.5×	165 0.2×	591 0.9×	60	6.0k
Eric Metzen Germany	30	3.8k 0.8×	71 0.1×	590 0.5×	1.1k 1.1×	524 0.8×	51	6.8k
Dennis K. Watson United States	41	3.6k 0.8×	62 0.1×	1.3k 1.0×	195 0.2×	500 0.8×	106	5.8k

Countries citing papers authored by Lawreen H. Connors

Since Specialization

Citations

This map shows the geographic impact of Lawreen H. Connors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawreen H. Connors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawreen H. Connors more than expected).

Fields of papers citing papers by Lawreen H. Connors

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawreen H. Connors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawreen H. Connors. The network helps show where Lawreen H. Connors may publish in the future.

Co-authorship network of co-authors of Lawreen H. Connors

This figure shows the co-authorship network connecting the top 25 collaborators of Lawreen H. Connors. A scholar is included among the top collaborators of Lawreen H. Connors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawreen H. Connors. Lawreen H. Connors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Villacorta-Martín, Carlos, Jonathan Lindstrom-Vautrin, Devin Kenney, et al.. (2023). Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures. Amyloid. 30(4). 379–393. 3 indexed citations

Fine, Denise, Stephen Helmke, Farbod Raiszadeh, et al.. (2023). Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association. 12(15). e028973–e028973. 17 indexed citations

Prokaeva, Tatiana, Elena S. Klimtchuk, Brian Spencer, et al.. (2022). An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis. Amyloid. 30(2). 141–152. 2 indexed citations

Hung, Ivan, Brian Michael, Zhehong Gan, et al.. (2020). Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo. Biochemistry. 59(19). 1800–1803. 10 indexed citations

Berk, John L., Lawreen H. Connors, Gheorghe Doros, et al.. (2019). Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience. Circulation. 2 indexed citations

Arvanitis, Marios, Clarissa M. Koch, John L. Berk, et al.. (2018). Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Circulation Heart Failure. 11(2). e004000–e004000. 61 indexed citations

Tahir, Usman A., John S. Kim, Lawreen H. Connors, & Flora Sam. (2015). Clinical Characteristics of Survivors and Non-Survivors with Immunoglobulin Light Chain (AL) Cardiac Amyloid Heart Failure. Journal of Cardiac Failure. 21(8). S90–S90. 1 indexed citations

Connors, Lawreen H., et al.. (2014). Web-Enabled Subjective Test (WEST) Research Tools Manual. 2 indexed citations

Reddi, Honey V., Sarah M. Jenkins, Jason D. Theis, et al.. (2013). Homozygosity for the V122I Mutation in Transthyretin Is Associated with Earlier Onset of Cardiac Amyloidosis in the African American Population in the Seventh Decade of Life. Journal of Molecular Diagnostics. 16(1). 68–74. 32 indexed citations

10.

Girnius, Saulius, Martha Skinner, Brian Spencer, et al.. (2012). A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid. 19(4). 182–185. 19 indexed citations

11.

Ren, Ruiyi, Haiyan Gong, Martha Skinner, et al.. (2010). Role of Glycosaminoglycan Sulfation in the Formation of Immunoglobulin Light Chain Amyloid Oligomers and Fibrils. Journal of Biological Chemistry. 285(48). 37672–37682. 43 indexed citations

12.

Seldin, David C., Lawreen H. Connors, Martha Skinner, et al.. (2009). Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: A case report with literature review. Amyloid. 16(2). 103–107. 15 indexed citations

13.

Lavatelli, Francesca, David H. Perlman, Brian Spencer, et al.. (2008). Amyloidogenic and Associated Proteins in Systemic Amyloidosis Proteome of Adipose Tissue. Molecular & Cellular Proteomics. 7(8). 1570–1583. 115 indexed citations

14.

Migrino, Raymond Q., et al.. (2007). Abstract 1708: Primary Amyloidosis Light Chains Impair Endothelium-Dependent Vasodilation in Human Arterioles. Circulation. 116. 1 indexed citations

15.

Prokaeva, Tatiana, Brian Spencer, Al Ozonoff, et al.. (2007). Soft tissue, joint, and bone manifestations of AL amyloidosis: Clinical presentation, molecular features, and survival. Arthritis & Rheumatism. 56(11). 3858–3868. 97 indexed citations

16.

Kingsbury, Jonathan S., Elena S. Klimtchuk, Roger Théberge, Catherine E. Costello, & Lawreen H. Connors. (2007). Expression, purification, and in vitro cysteine-10 modification of native sequence recombinant human transthyretin. Protein Expression and Purification. 53(2). 370–377. 22 indexed citations

17.

Trinkaus‐Randall, Vickery, et al.. (2005). Cellular Response of Cardiac Fibroblasts to Amyloidogenic Light Chains. American Journal Of Pathology. 166(1). 197–208. 40 indexed citations

18.

Connors, Lawreen H., Roger Théberge, James Skare, et al.. (1999). A new transthyretin variant (Ser2 sn) associated with familial amyloidosis in a Portuguese patient. Amyloid. 6(2). 114–118. 19 indexed citations

19.

Théberge, Roger, et al.. (1999). A new amyloidogenic transthyretin variant (Vail 22Ala) found in a compound heterozygous patient. Amyloid. 6(1). 54–58. 13 indexed citations

20.

Wally, Jeremy, Tracy Zhang, Thomas Ericsson, et al.. (1999). Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic κ1 light chain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1454(1). 49–56. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact